INTRODUCTION 1
Transposable elements play an important role in evolution which is demonstrated 2 by an estimated 50 genes within the human genome that are transposon-derived, 3
including genes vital to our adaptive immunity (16) and DNA repair (33). Amazingly, 4 sequences recognized as derived from transposable elements account for approximately 5 45% of the overall human genome (31) . Transposable elements can be broken down into 6 two main groups: those which rely on an RNA intermediate for remobilization (retro-7 elements) and those which are remobilized directly as DNA (DNA transposons). Fossils 8 of one group of DNA transposons, the Tc1/mariner-type, are found throughout nature. 9
Remnants, which have been deactivated through the accumulation of mutations over time 10 (21, 22), have been isolated from a variety of organisms including fish (22), Xenopus (30, 11 51), insects (49), C.elegans (48), Drosophila (47), and humans (43, 52) . Recognizing the 12 many potential uses of an active and efficient DNA transposon system, Ivics et al. 13 reconstructed a functional Tc1/mariner-like element from inactive transposon remnants 14 found in fish and named it Sleeping Beauty (SB) (21). Shortly following its description, 15 our group established the possible utility of this system as a means to genetically modify 16 somatic tissues in adult mammals to treat animal models of human disease (40, 57, 59) . 17 DNA transposons of the Tc1/mariner-type contain a simple structure in which the 18 only components required for transposition are inverted repeats (IRs), which flank the 19 DNA to be transposed, and Sleeping Beauty transposase. As with other DNA 20 transposons, SB transposition occurs through a "cut and paste" mechanism mediated by 21 binding to the IRs of Sleeping Beauty transposase, which can be supplied either in cis 22 from an autonomous element or in trans from a non-autonomous element. The excision 23
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final) was added to the cells for a total of 24 hrs (media and inhibitor were changed once 1 at 12 hrs) and then the cells were analyzed by flow cytometry. within the plasmid backbone a SB transposase expression cassette driven by the 18 cytomegalovirus (CMV) promoter. We also generated two important control vectors that 19 are incapable of SB-mediated integration due to a deficiency in either i) transposon 20 inverted repeats (pRSV-eYFP.CMV-SB) or ii) a source of SB transposase (pT/RSV-21 eYFP). 22
To generate clonal cell lines, we transiently transfected each of these vectors into 1 HeLa cells and incubated them for 48-72 hrs to permit SB-mediated transposition into 2 host cell chromosomes. Under these experimental conditions, the vast majority of 3 fluorescent signal intensity at this time should be derived from episomal-based forms of 4 the transfected plasmids, thereby permitting separation and cloning of individually 5 transfected cells via fluorescent activated cell sorting (FACS) analysis. Transfected cells 6
were trypsinized and single eYFP-, eGFP-and dmGFP-positive cells distributed to each 7 well of a 96-well plate in the presence of appropriate growth media. In an effort to avoid 8 a sorting bias in the initial stages of our studies, we gated cells such that the decision for 9 plating single cells was determined only by whether it was positive or negative, without 10 any consideration for the relative level of reporter gene expression. After FACS, the 11 individually dispensed cells were expanded into cell lines and passaged repeatedly on 6-12 cm diameter plates for a period of 10 weeks to ensure loss of any episomal plasmid. In 13 this manner, we generated a total of 450 different clonal cell lines for subsequent 14 molecular analyses (Table 1) . 15
16
Analysis of SB-mediated integration. Each of the 450 newly isolated cell lines was 17 screened for stable transposon integration via Southern blot analysis in order to i) verify 18 loss of episomal plasmid DNA, and ii) determine the number of integrations per cell line 19 ( Figure 2 ). As summarized in Table 1 , all three cis-acting SB vectors showed an 20 integration efficiency of 41%-52%, which is significantly higher than the 2-3% value 21 previously reported within first-generation SB systems (13, 64) . These data suggest that a 22 large proportion of SB elements may undergo post-integrative gene silencing in 23 mammalian cells, events which would ordinarily go undetected in screening methods that 1 rely on antibiotic selection and thus require persistent transposon expression. 2 Importantly, control vectors lacking either SB inverted repeats (pRSV-eYFP.CMV-SB) 3 or a source of SB transposase (pT/RSV-eYFP) yielded integration efficiencies of 4 approximately 0-6.5%. This data suggests that the elevated integration frequencies 5 observed with each of the experimental transposon vectors is the result of SB-mediated 6 DNA transposition. Additionally, the integration frequencies of the cis-acting vectors did 7 not follow a Poisson distribution ( Figure 2D ), further verifying that integration within our 8 system occurs through a specific SB-mediated integration mechanism and not via random 9 integration. 10 11 Quantitative analysis of transposon gene expression. We analyzed cell lines that 12 contained a single integration event over time via flow cytometry in order to define the 13 expression profile associated with each cell line. At 12 weeks post-transfection, all three 14 cis-acting vectors experienced similar levels of transgene silencing, ranging from 13-23% 15 (Table 2 ). These data suggest that differences in promoter (e.g., RSV vs. EF1 ), 16 transgene (e.g., eYFP vs. eGFP) or CpG content (e.g., eGFP vs. dmGFP) were unlikely to 17 significantly influence the degree of SB transposon silencing in the soma at this time 18 point. Cell lines were followed for an additional 30 weeks in order to determine whether 19 the observed degree of silencing would remain stable or progress over time. eYFP. Using this approach, we found that the majority of integrated transposons 20 experienced at least some level of DNA methylation , with 53% (9/17) of the cell lines 21 (16, 24, 26, 34, 115, 116, 118, 142 and 162) showing significant digestion in the presence 22 of McrBC (Figure 4) . 23
To investigate possible functional consequences of this methylation, we studied 1 what effect, if any, the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (5-2 AzaC) had on the expression of these transposon-encoded transgenes. 5-AzaC is 3 frequently used to assess the role of DNA methylation in a given cellular process and 4 functions during DNA synthesis by covalently attaching to cellular methyltransferase 5 enzymes, thereby blocking subsequent methylation of newly synthesized DNA (4). Since 6 5-AzaC functions only in dividing cells, we added it to subconfluent cells and grew them 7 in the presence of the inhibitor for four days, at which time we analyzed each cell line for 8 eYFP expression by flow cytometry. As negative controls we included wild-type HeLa 9 cells and mock treated samples for each cell line. 10
After 5-AzaC treatment, all 17 single integration cell lines (except cell line 19) 11 created using pT/RSV-eYFP.CMV-SB experienced a significant increase in transgene 12 expression ( Figure 5 ). As summarized in Table 4 , not only did we observe an increase in 13 expression in cell lines that were already eYFP positive (cell lines 1, 16, 17, 37, 116, 118, 14 129, 140, 142 and 162) but we also observed reactivation within silenced cell lines (cell 15 lines 24, 26, 34, 50, 115 and 127) . These data indicate that in the context of integrated 16 Table 4 ). We observed a 4 significant increase in transposon expression in 41% (7/17) of cell lines (16, 17, 37, 116, 5 118, 140 and 162), and detected reactivation in four previously silenced cell lines (19, 24, 6 34 and 50). Only cell line 26 showed a negligible increase in eYFP expression in the 7 presence of TSA. These results indicate that histone deacetylation may also contribute to 8 post-integrative transposon silencing. 9
10
Recovery and mapping of transposon insertion sites. In an effort to gain more insight 11 into the events leading to post-integrative gene silencing, we investigated the genomic 12 features associated with silenced and non-silenced transposons in pT/RSV-eYFP.CMV-13 SB-derived cell lines. To do this, we used linker-mediated PCR (LM-PCR) to isolate the 14 genomic sequences immediately flanking the transposon (7) from two pools of genomic 15 DNA collected at week 12: i) one derived from ten expressing cell lines, and ii) one 16 derived from seven silenced clones. Although we were only able to unambiguously map 17 five clones from the expressing pool and two from the silenced pool, all five integrations 18 from the pool of high-expressing clones mapped to within 2 kb of a known or predicted 19 gene (Table 5) , perhaps indicating that within a non-selective system transposons located 20 within close proximity of endogenous genes may have a greater likelihood of maintaining 21 expression upon genomic insertion. Of the two silenced clones we successfully mapped, 22 one mapped >2 kilobases from the nearest predicted gene while the other localized within 23 the highly expressed (23) dihydropyrimidine dehydrogenase (DPYD) gene and may have 1 been silenced due to transcriptional interference (50), as has been seen within retroviruses 2 (15, 34, 35) . While these data do provide some much needed preliminary insight into 3 these regulatory events, the limited sample-size is much too low to make any definitive 4 conclusions herein. Future work in the field using more high-throughput screening 5 methods should thus prove invaluable in better clarifying this important issue. In this report, we have developed a novel non-selective, FACS-based method to 2 measure the frequency of Sleeping Beauty transposon integration, independent of its 3 expression, in cultured human cells. Using this unique approach, we demonstrate that 4 SB's true integrative potential is up to 25X-higher than previously reported selection-5 based estimates (i.e., 41-52% versus 2-3%). In addition, we have identified the existence 6 of an ill-defined post-integrative gene regulatory network that efficiently targets some 7 invading transposon sequences for transcriptional silencing in mammalian cells. 8
Our work indicates that post-integrative gene silencing can play a role in limiting 9 long-term SB-based expression and suggests that at least two types of potential silencing 10 "triggers" may be involved. In the case of "contextual" silencing, the expression of the 11 integrated transposon is predominantly influenced by the regional chromosomal 12 sequences to which it is now confined. This mode of gene silencing has also been 13 reported within the context of retrovirus-based systems (3, 8, 24, 25, 34, 35, 42, 54, 62) , 14 although the underlying mechanisms involved remain under investigation. In theory, 15 however, contextual silencing could originate from integration of the transposon into 16 regions that are inherently restrictive to gene expression (e.g., heterochromatin). 17
Alternatively, if a transposon were to integrate into a highly active region of the 18 chromosome, it is possible that such an event could also initiate a signaling cascade that 19 culminates in the selective repression of the invading sequence via RNAi or through 20 transcriptional interference. In the present study, we described our preliminary analyses 21 of three different cis-acting vectors and found similar levels of silencing after a twelve-22 week time period, a result that is highly consistent with a "cargo-independent" mode of 23 transposon silencing. Although the results of the integration site analyses performed 1 herein are also consistent with this contextual model, future large-scale investigations 2 will be needed to firmly establish the link between integration local and transposon 3 expression levels. 4
As indicated by the detailed work with pT/RSV-eYFP.CMV-SB, a second class 5 of silencing triggers exists which is dependent on the presence of specific sequences 6 and/or structural elements within the transposon itself. One such "intrinsic" element that 7 may serve to flag the transposon sequence as foreign (and thereby target it for silencing) 8 is DNA that is rich in CpG dinucleotides. Indeed, within the pT/RSV-eYFP.CMV-SB-9 derived cell lines we not only observed a general trend towards increased transposon 10 CpG methylation and progressive transgene silencing, but we also observed that many 11 silenced clones could be reactivated in the presence of the DNA methyltransferase 12 suggests that DNA methyltransferases can inhibit transcription both directly (20, 28, 37) 23 and indirectly via interaction with the histone deacetylases involved in chromatin 1 condensation (6, 10-12, 28). Although CpG methylation often correlates with the 2 transcriptional silencing of retroviral sequences (8, 19, 25, 32, 37, 38, (53) (54) (55) 62) , our 3 study is the first to establish a similar correlation within a mammalian transposon system. 4
As such, our findings indicate that DNA methylation may play a general role in some 5 host cell mechanisms which recognize then silence invading genetic sequences, which is 6 collaborated by data from a variety of biological systems. For instance, Drosophila lack 7 a DNA methlation system and are unable to effectively repress transposon activity and as 8 a result 50-85% of all spontaneous Drosophila mutations are caused by transposon 9 insertions, as compared to less than 1% of human mutations (9, 36, 63) . In addition, the 10 suppression of DNA methylation in plants (18, 26, 41) , Dictyostelium (29) , and 11 mammalian germ cells (2) has been shown to lead to reactivation of endogenous 12 transposon sequences, suggesting that CpG methylation-based silencing mechanisms 13 (and perhaps others) are evolutionarily conserved presumably because they play an 14 integral role in minimizing the damage caused by invading genetic parasites. 15
Another epigenetic modification that may contribute to the transcriptional 16 repression of integrated transposons is the deacetylation of chromatin-bound histones. 17
Using the histone deacetylase inhibitor TSA, we have found that post-integrative 18 transposon silencing can occur in a histone deacetylation-dependent manner. Similar 19 findings have been reported from the retroviral field (17, 25, 33, 38, 39, 54, 55) . 20
Interestingly, the silencing induced by elements intrinsic to the transposon (as 21 described for pT/RSV-eYFP.CMV-SB) does not appear to uniformly apply to all SB 22 transposons since we observed little long-term change in transgene expression within the 23 context of pT/EF1 -eGFP.CMV-SB-and pT/dmEF1 -dmGFP.CMV-SB-derived clones. 1
We believe the lack of continued silencing within these two transposons was due mainly 2 to our switch from the Rous Sarcoma Virus-derived promoter to the endogenous human 3 EF1 promoter, since such a change has been previously documented to positively affect 4 persistence of transgene expression (14). Several possibilities exist for why such a 5 change in promoter could elicit such a strong alteration in long-term gene expression 6 patterns. For example, the RSV promoter itself could be acting as a nucleating factor for 7 silencing, or perhaps the RSV promoter is simply not strong enough to overcome the 8 silencing effect of the high CpG dinucleotide concentration found within the pT/RSV-9 eYFP.CMV-SB transposon. The exact cause for the difference in silencing between our 10 RSV and EF1 transposons was not fully elucidated within the context of this study. 11 Nonetheless, our finding that some SB transposons are subject to high levels of post-12 integrative gene silencing remains an important consideration for future transposon 13 studies. 14 Within our study, the transposons containing a virus-derived promoter (RSV) 15 were silenced over time, and as a result had we employed an antibiotic selection scheme 16 in measuring the system's integration efficiency then we would have likely 17 underestimated the true integration efficiency. Importantly, it is worth noting that 18 previous estimates of SB's integration efficiency not only relied upon an antibiotic 19 selection scheme but they also employed virus-derived promoters (Cytomegalovirus [13] 20 and SV40 virus [64] ) to drive expression of their respective antibiotic resistance markers, 21 which may explain why these studies observed a much lower integration efficiency for 22 SB than what was demonstrated within our study. 23
The Sleeping Beauty transposon system represents an increasingly important 1 vehicle for in vivo gene delivery. At present, however, much of the effort directed 2 towards successfully adapting this and other DNA transposons to a clinical setting have 3 focused to a large extent on obtaining improved integration frequencies in target cells via 4 mutation of transposon (donor) and/or transposase (helper) components (1, 13, 27, 60, 5 64). Our work presented herein suggest that SB's integration efficiency may not be as 6 great a barrier as previously thought, and implies that a greater emphasis on post-7 integrative regulatory mechanisms may ultimately prove more productive in perfecting 8 SB for a clinical environment. First, more studies are required for identifying, and 9 ultimately deleting and/or altering, all intrinsic silencing triggers embedded within the 10 transposon while maintaining its integration properties. Second, extreme care should be 11 applied when making the decision as to what promoter will be used since our data 12 indicates this may be one of the major determinants of persistence of transgene 13 expression. And third, in order to alleviate the impact of contextual silencing entirely, it 14 would be beneficial if researchers could also modify transposon systems in such a way as 15 to promote integration into sites predetermined to be suitable for long-term expression 16 (56, 58). Based on the degree of transposon silencing observed in our studies, all of these 17 approaches, while experimentally challenging, are likely to prove essential in the 18 optimization of transposons (and possibly retroviruses) for clinical gene therapy. 19
Additionally, it will also be important to insure that the maximization of transgene 20 expression within the SB system does not affect expression of local endogenous 21 sequences, which perhaps could be accomplished through the use of efficient poly-A 22 sequences to prevent 3'-readthrough and insulators to limit chromatin influences. 23
Finally, while our study does identify post-integrative gene silencing as an area of 1 transposon biology warranting further investigation, we remain entirely optimistic of 2 Sleeping Beauty's therapeutic future since we also demonstrated that SB has the ability to 3 integrate at sufficiently high-levels for applications within the field of gene therapy. 4
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